Premium
Astria Therapeutics Inc (ATXS)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for... Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.07 | -1.11821086262 | 6.26 | 6.88 | 5.84 | 282785 | 6.28226604 | CS |
| 4 | -1.24 | -16.6890982503 | 7.43 | 7.49 | 5.84 | 226189 | 6.65410306 | CS |
| 12 | -3.56 | -36.5128205128 | 9.75 | 9.99 | 5.84 | 287652 | 7.91159493 | CS |
| 26 | -4.9 | -44.1839495041 | 11.09 | 12.92 | 5.84 | 310791 | 9.75592476 | CS |
| 52 | -8.63 | -58.2321187584 | 14.82 | 16.9 | 5.84 | 492430 | 11.15397687 | CS |
| 156 | 0.07 | 1.14379084967 | 6.12 | 16.9 | 2.36 | 328590 | 10.38480998 | CS |
| 260 | -2.34 | -27.4325908558 | 8.53 | 16.9 | 2.36 | 290737 | 10.28391395 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
